• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胶质母细胞瘤患者的临床特征和预后:基于 SEER 数据库对 1674 例患者生存分析的综述。

Clinical characteristics and prognosis of patients with glioblastoma: A review of survival analysis of 1674 patients based on SEER database.

机构信息

Department of Neurosurgery, General Hospital of Northern Theater Command, Shenyang, China.

Department of Pathology, Xijing Hospital, Air Force Medical University, Xi'an, Shaanxi, China.

出版信息

Medicine (Baltimore). 2022 Nov 25;101(47):e32042. doi: 10.1097/MD.0000000000032042.

DOI:10.1097/MD.0000000000032042
PMID:36451503
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9704894/
Abstract

BACKGROUND

To fully understand the clinical features and prognosis of Glioblastoma (GBM), we extracted the data from the Surveillance, Epidemiology, and End Results (SEER) database and performed a series of analyses.

METHODS

We retrospectively analyzed the data of 1674 patients with GBM obtained from the SEER database from 1983 to 2015. Kaplan-Meier analysis was performed to calculate the survival rate, and the log-rank test was used to analyze the survival outcomes.

RESULTS

Older patients with GBM had a worse survival period (P < .05). Laterality had no effect on the prognosis (P > .05). Patients with high-grade gliomas may have a shorter lifespan (P < .05). In terms of overall survival (OS) and disease specificity, all 3 classical treatments failed to improve the life expectancy (P > .05). In adult patients with GBM, we found that age, tumor grade, surgery, radiotherapy, and chemotherapy were independent risk factors for all-cause mortality. In the univariate disease-specific analysis, age, tumor grade, surgery, radiotherapy, and chemotherapy were independent risk factors. However, in multivariate disease-specific analysis, the results showed that only tumor grade and surgery were independent risk factors for GBM.

CONCLUSIONS

Older patients diagnosed with GBM have worse survival, and patients with glioma of higher grades have a shorter lifespan. Age, grade, surgery, radiation therapy, and chemotherapy were independent prognostic factors for patients with GBM.

摘要

背景

为了充分了解胶质母细胞瘤(GBM)的临床特征和预后,我们从监测、流行病学和最终结果(SEER)数据库中提取数据,并进行了一系列分析。

方法

我们回顾性分析了 1983 年至 2015 年从 SEER 数据库获得的 1674 例 GBM 患者的数据。采用 Kaplan-Meier 分析计算生存率,对数秩检验分析生存结果。

结果

年龄较大的 GBM 患者的生存期较差(P<0.05)。侧别对预后无影响(P>0.05)。高级别胶质瘤患者的寿命可能较短(P<0.05)。在总生存期(OS)和疾病特异性方面,3 种经典治疗方法均未能提高预期寿命(P>0.05)。在 GBM 成年患者中,我们发现年龄、肿瘤分级、手术、放疗和化疗是全因死亡率的独立危险因素。在单变量疾病特异性分析中,年龄、肿瘤分级、手术、放疗和化疗是独立的危险因素。然而,在多变量疾病特异性分析中,结果表明只有肿瘤分级和手术是 GBM 的独立危险因素。

结论

诊断为 GBM 的老年患者的生存率较差,肿瘤级别较高的患者寿命较短。年龄、分级、手术、放疗和化疗是 GBM 患者的独立预后因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53a2/9704894/502b23d819d7/medi-101-e32042-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53a2/9704894/b513bd353ce6/medi-101-e32042-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53a2/9704894/0045f895fcd0/medi-101-e32042-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53a2/9704894/502b23d819d7/medi-101-e32042-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53a2/9704894/b513bd353ce6/medi-101-e32042-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53a2/9704894/0045f895fcd0/medi-101-e32042-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53a2/9704894/502b23d819d7/medi-101-e32042-g003.jpg

相似文献

1
Clinical characteristics and prognosis of patients with glioblastoma: A review of survival analysis of 1674 patients based on SEER database.胶质母细胞瘤患者的临床特征和预后:基于 SEER 数据库对 1674 例患者生存分析的综述。
Medicine (Baltimore). 2022 Nov 25;101(47):e32042. doi: 10.1097/MD.0000000000032042.
2
Clinical features associated with the efficacy of chemotherapy in patients with glioblastoma (GBM): a surveillance, epidemiology, and end results (SEER) analysis.与胶质母细胞瘤(GBM)患者化疗疗效相关的临床特征:监测、流行病学和最终结果(SEER)分析。
BMC Cancer. 2021 Jan 19;21(1):81. doi: 10.1186/s12885-021-07800-0.
3
Prognosis of Patients With Brainstem Glioblastoma Based on "age, surgery and radiotherapy": A SEER Database Analysis.基于“年龄、手术和放疗”的脑干胶质母细胞瘤患者预后:SEER 数据库分析。
Technol Cancer Res Treat. 2022 Jan-Dec;21:15330338221082760. doi: 10.1177/15330338221082760.
4
Prognostic factors and clinical outcomes in adult primary gliosarcoma patients: a Surveillance, Epidemiology, and End Results (SEER) analysis from 2004 to 2015.成人原发性胶质肉瘤患者的预后因素及临床结局:一项2004年至2015年的监测、流行病学和最终结果(SEER)分析
Br J Neurosurg. 2020 Apr;34(2):161-167. doi: 10.1080/02688697.2019.1699903. Epub 2019 Dec 12.
5
A systematic review of overall survival in pediatric primary glioblastoma multiforme of the spinal cord.脊髓原发性多形性胶质母细胞瘤患儿总生存期的系统评价。
J Neurosurg Pediatr. 2017 Feb;19(2):239-248. doi: 10.3171/2016.8.PEDS1631. Epub 2016 Nov 4.
6
Clinical Characteristics and Prognostic Analysis of Glioma in Human Immunodeficiency Virus-Infected Patients.人类免疫缺陷病毒感染患者胶质瘤的临床特征及预后分析
World Neurosurg. 2018 Jun;114:e218-e223. doi: 10.1016/j.wneu.2018.02.168. Epub 2018 Mar 8.
7
Prognostic factors of patients with Gliomas - an analysis on 335 patients with Glioblastoma and other forms of Gliomas.脑胶质瘤患者的预后因素分析——335 例胶质母细胞瘤和其他类型脑胶质瘤患者的分析。
BMC Cancer. 2020 Jan 15;20(1):35. doi: 10.1186/s12885-019-6511-6.
8
Giant cell glioblastoma: a glioblastoma subtype with distinct epidemiology and superior prognosis.巨细胞胶质母细胞瘤:一种具有独特流行病学和良好预后的胶质母细胞瘤亚型。
Neuro Oncol. 2009 Dec;11(6):833-41. doi: 10.1215/15228517-2008-123.
9
The prognostic significance of CDKN2A homozygous deletion in IDH-mutant lower-grade glioma and glioblastoma: a systematic review of the contemporary literature.IDH 突变型低级别胶质瘤和胶质母细胞瘤中 CDKN2A 纯合缺失的预后意义:当代文献的系统评价。
J Neurooncol. 2020 Jun;148(2):221-229. doi: 10.1007/s11060-020-03528-2. Epub 2020 May 8.
10
Patterns of care and outcomes of patients with pleomorphic xanthoastrocytoma: a SEER analysis.多形性黄色星形细胞瘤患者的治疗模式和结局:一项 SEER 分析。
J Neurooncol. 2012 Oct;110(1):99-104. doi: 10.1007/s11060-012-0939-8. Epub 2012 Jul 28.

引用本文的文献

1
Immunological Insights into Photodynamic Therapy of Glioblastoma Multiforme.多形性胶质母细胞瘤光动力疗法的免疫学见解
Molecules. 2025 Jul 24;30(15):3091. doi: 10.3390/molecules30153091.
2
Diffuse hemispheric glioma, H3 G34-mutant: defining the clinical picture through a single institution case series and literature analysis.弥漫性半球胶质瘤,H3 G34突变型:通过单机构病例系列和文献分析界定临床特征
J Neurooncol. 2025 May 22. doi: 10.1007/s11060-025-05028-7.
3
Exploring the Role of ADCs in Brain Metastases and Primary Brain Tumors: Insight and Future Directions.
探索抗体药物偶联物在脑转移瘤和原发性脑肿瘤中的作用:见解与未来方向
Cancers (Basel). 2025 May 7;17(9):1591. doi: 10.3390/cancers17091591.
4
Identification of the high-risk population facing early death in older patients with primary intracranial glioma: a retrospective cohort study.原发性颅内胶质瘤老年患者早期死亡高危人群的识别:一项回顾性队列研究。
Front Endocrinol (Lausanne). 2025 Mar 3;16:1546530. doi: 10.3389/fendo.2025.1546530. eCollection 2025.
5
Successful application of dietary ketogenic metabolic therapy in patients with glioblastoma: a clinical study.饮食性生酮代谢疗法在胶质母细胞瘤患者中的成功应用:一项临床研究。
Front Nutr. 2025 Feb 18;11:1489812. doi: 10.3389/fnut.2024.1489812. eCollection 2024.
6
Effect of radiation after surgery on the prognosis of children with Wilms tumor.手术放疗对儿童肾母细胞瘤预后的影响。
PLoS One. 2024 Sep 19;19(9):e0308824. doi: 10.1371/journal.pone.0308824. eCollection 2024.
7
Results from a phase I study of 4--[131I]iodo-phenylalanine ([I]IPA) with external radiation therapy in patients with recurrent glioblastoma (IPAX-1).一项针对复发性胶质母细胞瘤患者的4-[¹³¹I]碘苯丙氨酸([I]IPA)联合外照射放疗的I期研究(IPAX-1)结果。
Neurooncol Adv. 2024 Jul 29;6(1):vdae130. doi: 10.1093/noajnl/vdae130. eCollection 2024 Jan-Dec.
8
Advancing precision prognostication in neuro-oncology: Machine learning models for data-driven personalized survival predictions in IDH-wildtype glioblastoma.推进神经肿瘤学中的精准预后预测:用于IDH野生型胶质母细胞瘤数据驱动的个性化生存预测的机器学习模型
Neurooncol Adv. 2024 Jun 11;6(1):vdae096. doi: 10.1093/noajnl/vdae096. eCollection 2024 Jan-Dec.
9
A Roadmap of CAR-T-Cell Therapy in Glioblastoma: Challenges and Future Perspectives.嵌合抗原受体 T 细胞疗法治疗胶质母细胞瘤的路线图:挑战与未来展望。
Cells. 2024 Apr 23;13(9):726. doi: 10.3390/cells13090726.
10
Unusual presentation of glioblastoma in the brainstem: a case report of a diffuse pontine glioblastoma multiforme and surgical management.脑干胶质母细胞瘤的罕见表现:一例弥漫性桥脑多形性胶质母细胞瘤病例报告及手术治疗
Front Oncol. 2024 Mar 13;14:1279897. doi: 10.3389/fonc.2024.1279897. eCollection 2024.